These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24405304)

  • 1. Transmission of hepatitis E virus by transfusion: what is the risk?
    Nelson KE
    Transfusion; 2014 Jan; 54(1):8-10. PubMed ID: 24405304
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence and 9-year incidence of hepatitis E virus infection among North Italian blood donors: Estimated transfusion risk.
    Spreafico M; Raffaele L; Guarnori I; Foglieni B; Berzuini A; Valenti L; Gerosa A; Colli A; Prati D
    J Viral Hepat; 2020 Aug; 27(8):858-861. PubMed ID: 32196831
    [No Abstract]   [Full Text] [Related]  

  • 3. Seroprevalence and incidence of hepatitis E virus infection in German blood donors.
    Juhl D; Baylis SA; Blümel J; Görg S; Hennig H
    Transfusion; 2014 Jan; 54(1):49-56. PubMed ID: 23441647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus infection among blood donors in the South Caribbean: is screening warranted?
    Schreuder I; Limper M; Gerstenbluth I; Osterhaus AD; van Veen MG; Scherbeijn SM; van Gorp EC; Duits AJ
    Neth J Med; 2016 Jan; 74(1):51-3. PubMed ID: 26819367
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of anti-HEV IgM among blood donors in Egypt.
    Ibrahim EH; Abdelwahab SF; Nady S; Hashem M; Galal G; Sobhy M; Saleh AS; Shata MT
    Egypt J Immunol; 2011; 18(2):47-58. PubMed ID: 23082470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E virus and blood donors in Germany.
    Baylis SA; Nick S; Blümel J; Micha Nübling C
    Vox Sang; 2010 Apr; 98(3 Pt 2):479. PubMed ID: 20136793
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis E Virus Prevalence among Blood Donors, Ouagadougou, Burkina Faso.
    Traoré KA; Ouoba JB; Rouamba H; Nébié YK; Dahourou H; Rossetto F; Traoré AS; Barro N; Roques P
    Emerg Infect Dis; 2016 Apr; 22(4):755-7. PubMed ID: 26982195
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.
    Hoad VC; Seed CR; Fryk JJ; Harley R; Flower RLP; Hogema BM; Kiely P; Faddy HM
    Vox Sang; 2017 Oct; 112(7):614-621. PubMed ID: 28833229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States.
    Baylis SA; Gärtner T; Nick S; Ovemyr J; Blümel J
    Vox Sang; 2012 Jul; 103(1):89-90. PubMed ID: 22220775
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis E virus and implications for blood supply safety, Australia.
    Shrestha AC; Seed CR; Flower RL; Rooks KM; Keller AJ; Harley RJ; Chan HT; Holmberg JA; Faddy HM
    Emerg Infect Dis; 2014 Nov; 20(11):1940-2. PubMed ID: 25341023
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis E and blood donation safety in selected European countries: a shift to screening?
    Domanović D; Tedder R; Blümel J; Zaaijer H; Gallian P; Niederhauser C; Sauleda Oliveras S; O'Riordan J; Boland F; Harritshøj L; Nascimento MSJ; Ciccaglione AR; Politis C; Adlhoch C; Flan B; Oualikene-Gonin W; Rautmann G; Strengers P; Hewitt P
    Euro Surveill; 2017 Apr; 22(16):. PubMed ID: 28449730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease.
    Dalton HR; Stableforth W; Thurairajah P; Hazeldine S; Remnarace R; Usama W; Farrington L; Hamad N; Sieberhagen C; Ellis V; Mitchell J; Hussaini SH; Banks M; Ijaz S; Bendall RP
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):784-90. PubMed ID: 18617784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis E virus among male blood donors in Tabriz, Islamic Republic of Iran.
    Taremi M; Gachkar L; MahmoudArabi S; Kheradpezhouh M; Khoshbaten M
    East Mediterr Health J; 2007; 13(1):98-102. PubMed ID: 17546911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-associated hepatitis E, France.
    Colson P; Coze C; Gallian P; Henry M; De Micco P; Tamalet C
    Emerg Infect Dis; 2007 Apr; 13(4):648-9. PubMed ID: 17561564
    [No Abstract]   [Full Text] [Related]  

  • 15. Europe's new hepatitis problem.
    Kupferschmidt K
    Science; 2016 Aug; 353(6302):862-3. PubMed ID: 27563081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis e antibodies in blood donors, hemodialysis patients and in normal people].
    Knödler B; Hiller J; Löliger CC; Kühnl L
    Beitr Infusionsther Transfusionsmed; 1994; 32():124-7. PubMed ID: 9480068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis E virus: Blood transfusion implications].
    Gallian P; Piquet Y; Assal A; Djoudi R; Chiaroni J; Izopet J; Tiberghien P
    Transfus Clin Biol; 2014 Nov; 21(4-5):173-7. PubMed ID: 25267201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of hepatitis E virus antibodies in blood donors and other population groups in southern Chile].
    Ibarra H; Riedemann S; Reinhardt G; Frieck P; Siegel F; Toledo C; Calvo M; Froösner G
    Rev Med Chil; 1997 Mar; 125(3):275-8. PubMed ID: 9460262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of Hepatitis E Virus.
    Geng Y; Wang Y
    Adv Exp Med Biol; 2016; 948():89-112. PubMed ID: 27738981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis E in transfusion-dependent thalassaemia patients, in Greece: a single centre experience.
    Klonizakis P; Gioula G; Exindari M; Apostolou C; Kotsiafti A; Vlachaki E
    Vox Sang; 2017 Oct; 112(7):678-679. PubMed ID: 28891120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.